|
Market Closed -
Warsaw S.E.
11:55:50 2026-09-02 EDT
|
5-day change | 1st Jan Change | ||
| 130.00 PLN | -1.07% |
|
-7.28% | -4.55% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 112M | - | - | |||
| 3.88B | - | ||||
| 3.75B | - | ||||
| 3.49B | |||||
| 2.53B | - | - | |||
| 2.21B | - | - | - | - |
- Stock Market
- Stocks
- SCP Stock
- Charts Scope Fluidics S.A.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
